{"id":"NCT02509481","sponsor":"Colorado State University","briefTitle":"Repeat Ivermectin Mass Drug Administrations for Control of Malaria: a Pilot Safety and Efficacy Study","officialTitle":"Repeat Ivermectin Mass Drug Administrations for Control of Malaria: a Pilot Safety and Efficacy Study","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2015-06","primaryCompletion":"2015-11","completion":"2015-12","firstPosted":"2015-07-28","resultsPosted":"2019-01-04","lastUpdate":"2019-01-04"},"enrollment":2712,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"TREATMENT"},"conditions":["Malaria","Lymphatic Filariasis"],"interventions":[{"type":"DRUG","name":"Ivermectin","otherNames":["Mectizan"]},{"type":"DRUG","name":"Albendazole","otherNames":[]}],"arms":[{"label":"Single MDA","type":"ACTIVE_COMPARATOR"},{"label":"Repeated MDA","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to determine whether repeated ivermectin mass drug administrations to Burkinab√© villagers, performed in three week intervals over the rainy-season, is well-tolerated and safe, and also effective in reducing local malaria transmission and thus clinical malaria episodes in treated village children.","primaryOutcome":{"measure":"Incidence of Clinical Malaria Episodes","timeFrame":"Approximately 18 weeks, from the start of the first MDA to 3 weeks following the last MDA in the Experimental arm","effectByArm":[{"arm":"Single MDA","deltaMin":2.49,"sd":null},{"arm":"Repeated MDA","deltaMin":2,"sd":null}],"pValues":[]},"eligibility":{"minAge":null,"sex":"ALL","healthyVolunteers":true,"inclusionCount":2,"exclusionCount":6},"locations":{"siteCount":2,"countries":["United States","Burkina Faso"]},"refs":{"pmids":["30878222"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":10,"n":1265},"commonTop":["acute malnutrition","malaria","pruritis","vomiting","fever"]}}